Jiangsu Yuyue Medical Equipment & Supply (002223) Fundamentals 2026 — P/E 21.7x, Revenue Analysis | SniperIQ
Jiangsu Yuyue Medical Equipment & Supply (002223) is a CN-listed Healthcare company in Medical - Instruments & Supplies with a market capitalization of ¥27.9B, trading at ¥27.87 on the SHZ. This SniperIQ fundamentals page covers Jiangsu Yuyue Medical Equipment & Supply's valuation (P/E 21.7x, P/B 2.0x), profitability (net margin 16.3%), revenue (¥7.9B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Jiangsu Yuyue Medical Equipment & Supply's market cap?
Jiangsu Yuyue Medical Equipment & Supply (002223) has a market capitalization of approximately ¥27.9B, trading at ¥27.87 on the SHZ. Market cap moves with the live share price.
What is Jiangsu Yuyue Medical Equipment & Supply's P/E ratio?
Jiangsu Yuyue Medical Equipment & Supply's trailing twelve-month P/E ratio is 21.7x, with a price-to-book (P/B) of 2.0x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Jiangsu Yuyue Medical Equipment & Supply?
Jiangsu Yuyue Medical Equipment & Supply runs a net profit margin of 16.3%, a gross margin of 50.0%, and an operating margin of 16.9%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Jiangsu Yuyue Medical Equipment & Supply generate?
Jiangsu Yuyue Medical Equipment & Supply reported revenue of ¥7.9B for fiscal year 2025, with net income of ¥1.5B and earnings per share (EPS) of 1.48. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Jiangsu Yuyue Medical Equipment & Supply pay a dividend?
Jiangsu Yuyue Medical Equipment & Supply offers a trailing dividend yield of about 3.6%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Jiangsu Yuyue Medical Equipment & Supply financially healthy?
Jiangsu Yuyue Medical Equipment & Supply carries a debt-to-equity ratio of 0.05x and a current ratio of 2.35x, with a market beta of 0.19. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Jiangsu Yuyue Medical Equipment & Supply a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Jiangsu Yuyue Medical Equipment & Supply (002223) the key facts are: market cap ¥27.9B, P/E 21.7x, revenue ¥7.9B, 52-week range 23.9-46.31. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Jiangsu Yuyue Medical Equipment & Supply's full fundamentals live
Get Jiangsu Yuyue Medical Equipment & Supply's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.